Lexicon Pharmaceuticals, Inc. (LXRX) Financial Statements (2024 and earlier)

Company Profile

Business Address 2445 TECHNOLOGY FOREST BLVD.
THE WOODLANDS, TX 77381
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments218,427256,739105,937138,357136,20361,968
Cash and cash equivalents21,116102,27126,00146,34518,83421,450
Short-term investments197,311154,46879,93692,012117,36940,518
Receivables318685261283934
Inventory, net of allowances, customer advances and progress billings336172    
Inventory336172    
Other current assets4,2916,1243,3482,4812,8212,896
Total current assets:223,372263,720109,546140,866139,06364,898
Noncurrent Assets
Operating lease, right-of-use asset5,687     
Property, plant and equipment2,1342,2022,2072,0719321,035
Intangible assets, net (including goodwill)44,54344,54344,54344,54344,54344,543
Goodwill44,54344,54344,54344,54344,54344,543
Other noncurrent assets7436,2596,4206,8197,1471,849
Total noncurrent assets:53,10753,00453,17053,43352,62247,427
TOTAL ASSETS:276,479316,724162,716194,299191,685112,325
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities32,26126,10920,37123,17218,44516,862
Accounts payable12,03610,50110,31110,3959,4277,347
Accrued liabilities20,22515,60810,06012,7779,0189,515
Total current liabilities:32,26126,10920,37123,17218,44516,862
Noncurrent Liabilities
Long-term debt and lease obligation, including:99,2655,4825,4545,4245,4381,002
Long-term debt, excluding current maturities99,26598,77248,845 23,78423,631
Other undisclosed long-term debt and lease obligation  (93,290)(43,391)5,424(18,346)(22,629)
Liabilities, other than long-term debt5,4435,4825,4545,4245,4381,002
Other liabilities  5,4825,4545,4245,4381,002
Operating lease, liability5,443     
Other undisclosed noncurrent liabilities  93,29043,39143,15518,34622,629
Total noncurrent liabilities:104,708104,25454,29954,00329,22224,633
Total liabilities:136,969130,36374,67077,17547,66741,495
Equity
Equity, attributable to parent139,510186,36188,046117,124144,01870,830
Common stock245245190189189150
Treasury stock, value(2,885)(2,885)(2,885)(2,061)(2,061)(2,061)
Additional paid in capital1,859,3461,855,6591,712,5581,709,1441,705,6071,608,730
Accumulated other comprehensive income (loss)(113)(100)(163)(428)(491)(150)
Accumulated deficit(1,717,083)(1,666,558)(1,621,654)(1,589,720)(1,559,226)(1,535,839)
Total equity:139,510186,36188,046117,124144,01870,830
TOTAL LIABILITIES AND EQUITY:276,479316,724162,716194,299191,685112,325

Income Statement (P&L) ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Revenues162317 139  
Cost of revenue(7)(29,616)    
Cost of goods and services sold(7)(8)    
Gross profit:155(29,299)    
Operating expenses(49,786)(14,941)31,166(30,306)23,13424,042
Other undisclosed operating income (loss)   (62,308)28(46,229)(48,049)
Operating loss:(49,631)(44,240)(31,142)(30,278)(23,095)(24,007)
Nonoperating income
(Other Nonoperating income)
3,0051,2961,029887572123
Interest and debt expense (3,899)(1,960)(1,821)(1,103)(864)(703)
Other undisclosed income from continuing operations before equity method investments, income taxes      
Loss from continuing operations:(50,525)(44,904)(31,934)(30,494)(23,387)(24,587)
Loss before gain (loss) on sale of properties:(23,387)(24,587)
Net loss:(50,525)(44,904)(31,934)(30,494)(23,387)(24,587)
Other undisclosed net loss attributable to parent      
Net loss available to common stockholders, diluted:(50,525)(44,904)(31,934)(30,494)(23,387)(24,587)

Comprehensive Income ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Net loss:(50,525)(44,904)(31,934)(30,494)(23,387)(24,587)
Comprehensive loss:(50,525)(44,904)(31,934)(30,494)(23,387)(24,587)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(13)6326563(341)(113)
Comprehensive loss, net of tax, attributable to parent:(50,538)(44,841)(31,669)(30,431)(23,728)(24,700)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: